FIELD: medicine.
SUBSTANCE: for complex treatment of diffuse toxic goiter, antithyroid drugs are used. At that, the patient takes thyrozol and beta-blocker egiloc until thyroid status compensation according to the template. Then, at supporting thyrotropic therapy background, the patient additionally takes, together with the same drugs, an inhibitor of angiotensin converting enzyme fosicard, 10 mg or 20 mg per day continuously, and an antioxidant agent mexidol, 125 mg or 250 mg two times a day, by 2 months courses with equal intervals, 3 times in year. In addition, performance of the cardiovascular system functions is monitored.
EFFECT: complex treatment of diffuse toxic goiter.
1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE RISK OF PERSISTING SEVERE PAIN WITH A SEVERITY OF MORE THAN 5 cm ON THE VISUAL ANALOGUE SCALE (VAS) FOR MORE THAN THREE MONTHS AFTER TOTAL HIP ARTHROPLASTY FOR OSTEOARTHRITIS | 2022 |
|
RU2793741C1 |
| METHOD FOR JOINT PAIN SYNDROME PREDICTION FOR PATIENTS WITH SIGNS OF CONNECTIVE TISSUE DYSPLASIA | 2016 |
|
RU2622597C1 |
| METHOD FOR DETERMINING HIGH RISK OF CAROTID ATHEROSCLEROSIS IN RHEUMATOID ARTHRITIS | 2020 |
|
RU2740246C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF DIFFERENT AUTOIMMUNE THYROID LESIONS | 2006 |
|
RU2315322C1 |
| METHOD OF TREATING HYPERTENSIVE DISEASE WITH CONCOMITANT VENOUS SYSTEM PATHOLOGY AND CONNECTIVE TISSUE DYSPLASIA | 2023 |
|
RU2818548C1 |
| METHOD FOR TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE AND CHRONIC BRAIN ISCHEMIA | 2021 |
|
RU2752065C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF HYPERTONIC DISEASE (HD) OF II STAGE AND ITS TREATMENT | 2011 |
|
RU2481062C1 |
| METHOD OF DIFFERENTIAL PRESCRIPTION OF β-ADRENORECEPTOR BLOCKING AGENTS IN PATIENTS WITH CHRONIC CARDIAC FAILURE | 2010 |
|
RU2454998C1 |
| METHOD FOR DETERMINING INDICATIONS TO SURGICAL TREATMENT OF CARDIAC ISCHEMIA PATIENTS SURVIVED AFTER MYOCARDIAL INFARCTION | 2004 |
|
RU2269934C1 |
| METHOD FOR OPTIMISATION OF MEN CARDIOTROPIC THERAPY AND HORMONE REPLACEMENT THERAPY IN CASE OF ANDROGENODEFICIENCY WITH ARTERIAL HYPERTENSION | 2016 |
|
RU2632449C1 |
